Showing results (951-960 of 1,155) with videos related to

Sort By:
Pageof 116
Leukemia|October 4, 2017
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathwayK Kondo, H Shaim, P A Thompson, et al.
Blut|September 1, 1981
Clinical and prognostic heterogeneity of non-Hodgkin lymphomas of high-grade malignancyU Schmalhorst, H Bartels, I Boll, et al.
Oncoimmunology|June 15, 2018
Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancerGuoying Zhou, Lisanne Noordam, Dave Sprengers, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2021
Intraoperative Electron Beam Radiation Therapy (IOERT) Versus High-Dose-Rate Intraoperative Brachytherapy (HDR-IORT) in Patients With an R1 Resection for Locally Advanced or Locally Recurrent Rectal CancerEva L K Voogt, Jan M van Rees, Jan A W Hagemans, et al.
Radiation Oncology (London, England)|July 10, 2026
Current clinical practice of radiotherapy for the non-operative treatment of patients with unresectable locally recurrent rectal cancer: results of a national survey of the dutch society for radiotherapy and oncologyF E C Vande Kerckhove, A E Verrijssen, R H N Tijssen, et al.
Journal of Clinical Medicine|July 26, 2020
Myocardial 18F-FDG Uptake Pattern for Cardiovascular Risk Stratification in Patients Undergoing Oncologic PET/CTAchi Haider, Susan Bengs, Katharina Schade, et al.
Frontiers in Immunology|December 24, 2019
The Envelope-Based Fusion Antigen GP120C14K Forming Hexamer-Like Structures Triggers T Cell and Neutralizing Antibody Responses Against HIV-1Suresh C Raman, Ernesto Mejías-Pérez, Carmen E Gomez, et al.
Blood|June 25, 2017
Tonic B-cell receptor signaling in diffuse large B-cell lymphomaOndrej Havranek, Jingda Xu, Stefan Köhrer, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 1, 2018
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell LymphomaSusan O'Brien, Peter Hillmen, Steven Coutre, et al.
The Lancet. Oncology|August 25, 2014
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 studyJan A Burger, Michael J Keating, William G Wierda, et al.
Pageof 116